Hua Han Bio-Pharmaceutical Holdings Ltd. (587):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Hua Han Bio-Pharmaceutical Holdings Ltd. (587) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH81956FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:香港
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,900見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥67,800見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥101,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Hua Han Bio-Pharmaceutical Holdings Ltd. (Hua Han) research, develops, produces and distributes herbal-based gynecological medicines and bio-pharmaceutical products. It offers prescription drugs that include yeosure series, camptothecine series, paclitaxel injection, xinshengha keli, and cefadroxil granules. Hua Han’s OTC products include fuke zhaizaowan, and huangqi granule. The company offers granules, capsules, small volume parenteral solutions, large volume parenteral solutions, lyophilized powder for injection, syrup, lotion, liniment, granules, capsules, tablets, powders, suppository, raw medicines, and raw medicines. It partners with Peking Union Medical College, and Nanjing Military Region Military Medical Institute, among others. Hua Han is headquartered in Hong Kong.

This comprehensive SWOT profile of Hua Han Bio-Pharmaceutical Holdings Ltd. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Hua Han Bio-Pharmaceutical Holdings Ltd. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Hua Han Bio-Pharmaceutical Holdings Ltd. – Key Information
Hua Han Bio-Pharmaceutical Holdings Ltd. – Overview
Hua Han Bio-Pharmaceutical Holdings Ltd. – Key Employees
Hua Han Bio-Pharmaceutical Holdings Ltd. – Key Employee Biographies
Hua Han Bio-Pharmaceutical Holdings Ltd. – Key Operational Heads
Hua Han Bio-Pharmaceutical Holdings Ltd. – Major Products and Services
Hua Han Bio-Pharmaceutical Holdings Ltd. – History
Hua Han Bio-Pharmaceutical Holdings Ltd. – Company Statement
Hua Han Bio-Pharmaceutical Holdings Ltd. – Locations And Subsidiaries
Hua Han Bio-Pharmaceutical Holdings Ltd. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Hua Han Bio-Pharmaceutical Holdings Ltd. – Business Description
Hua Han Bio-Pharmaceutical Holdings Ltd. – Corporate Strategy
Hua Han Bio-Pharmaceutical Holdings Ltd. – SWOT Analysis
SWOT Analysis – Overview
Hua Han Bio-Pharmaceutical Holdings Ltd. – Strengths
Hua Han Bio-Pharmaceutical Holdings Ltd. – Weaknesses
Hua Han Bio-Pharmaceutical Holdings Ltd. – Opportunities
Hua Han Bio-Pharmaceutical Holdings Ltd. – Threats
Hua Han Bio-Pharmaceutical Holdings Ltd. – Key Competitors

Section 3 – Company Financial Performance Charts

Hua Han Bio-Pharmaceutical Holdings Ltd. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Hua Han Bio-Pharmaceutical Holdings Ltd., Key Information
Hua Han Bio-Pharmaceutical Holdings Ltd., Key Ratios
Hua Han Bio-Pharmaceutical Holdings Ltd., Share Data
Hua Han Bio-Pharmaceutical Holdings Ltd., Major Products and Services
Hua Han Bio-Pharmaceutical Holdings Ltd., History
Hua Han Bio-Pharmaceutical Holdings Ltd., Key Employees
Hua Han Bio-Pharmaceutical Holdings Ltd., Key Employee Biographies
Hua Han Bio-Pharmaceutical Holdings Ltd., Key Operational Heads
Hua Han Bio-Pharmaceutical Holdings Ltd., Other Locations
Hua Han Bio-Pharmaceutical Holdings Ltd., Subsidiaries
Hua Han Bio-Pharmaceutical Holdings Ltd., Key Manufacturing facilities
Hua Han Bio-Pharmaceutical Holdings Ltd., Key Competitors
Hua Han Bio-Pharmaceutical Holdings Ltd., SWOT Analysis
Hua Han Bio-Pharmaceutical Holdings Ltd., Ratios based on current share price
Hua Han Bio-Pharmaceutical Holdings Ltd., Annual Ratios
Hua Han Bio-Pharmaceutical Holdings Ltd., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Hua Han Bio-Pharmaceutical Holdings Ltd., Performance Chart
Hua Han Bio-Pharmaceutical Holdings Ltd., Ratio Charts

★海外企業調査レポート[Hua Han Bio-Pharmaceutical Holdings Ltd. (587):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ICU Medical, Inc. (ICUI):企業のM&A・提携動向(医療機器分野)
    Summary ICU Medical, Inc. (ICU Medical) is a medical device company. It carries out the development, manufacture, distribution and sale of devices used in infusion therapy, oncology and critical care applications. The company’s major products include needlefree vascular access devices, closed system …
  • Woolworths Holdings Limited:企業の戦略・SWOT・財務分析
    SummaryWoolworths Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • ClearFlow, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary ClearFlow, Inc. (ClearFlow) is a medical device company. The company designs, develops, manufactures and markets anti-clogging platform of surgical drainage devices. It offers products such as PleuraFlow Systems and PleuraFlow Active Clearance Technology. ClearFlow’s PleuraFlow Active Cleara …
  • AVT McCormick Ingredients Pvt. Ltd.:企業の戦略・SWOT・財務分析
    SummaryAVT McCormick Ingredients Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the …
  • Societe Generale S.A.:企業のM&A・提携・投資分析
    Societe Generale S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Societe Generale S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Ahli United Bank K.S.C. (ALMUTAHE):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Ahli United Bank K.S.C." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly f …
  • TiVo, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' TiVo, Inc. Mergers and Acquisit …
  • Heat Biologics Inc (HTBX)-製薬・医療分野:企業M&A・提携分析
    Summary Heat Biologics Inc (Heat Biologics) is an immuno-oncology company that develops novel therapies to activate patient’s immune system against cancer. The company develops immune pan-antigen cytotoxic therapy, which is a therapeutic vaccine used in the treatment of cancer and infectious disease …
  • Banco Santander-Chile:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Banco Santander-Chile" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly fol …
  • Chr. Hansen A/S:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Chr. Hansen A/S Mergers and Acq …
  • Glaukos Corp (GKOS):企業財務及び戦略的SWOT分析
    Summary Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company’s products include microstent devices to treat glaucoma such as iStent trabecular micro-bypass stent for the treatment of mild- tomoderate ope …
  • Powerit Solutions, LLC:企業のM&A・提携動向(発電分野)
    Summary Powerit Solutions, LLC (Powerit Solutions), a subsidiary of Customized Energy Solutions Ltd. is an energy management technology company that provides energy management systems. The company provides solutions that include spara demand control, spara demand response, spara dynamic pricing and …
  • Raley’s Family of Fine Stores:企業概要及び戦略的SWOT分析
    Raley's Family of Fine Stores - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Service Point Solutions, S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Service Point Solutions, S.A. M …
  • SoftBank Group Corp. (Formerly SoftBank Corp.):企業の戦略・SWOT・財務分析
    SummarySoftBank Group Corp. (Formerly SoftBank Corp.) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ v …
  • Cellectis S.A. (ALCLS):企業のM&A・提携動向(医療機器分野)
    Summary Cellectis S.A. (Cellectis) is a biopharmaceutical company that focuses on the development of a novel therapeutics based on allogeneic T-cell for the treatment of cancer. The company offers therapeutic pipeline products that include products for hematopoietic tumors such as UCART19, UCART123, …
  • Syngen Biotech Co Ltd (8279):企業財務及び戦略的SWOT分析
    Summary Syngen Biotech Co Ltd (Syngen Biotech), a subsidiary of Standard Chem & Pharm Co Ltdis a biotechnology company that specializes in strain identification, micro-organism fermentation, recovery and purification. The company's product portfolio includes APIs, nutraceutical ingredients, function …
  • CNOOC Limited (883):企業のM&A・提携動向(エネルギー分野)
    Summary CNOOC Limited (CNOOC) is an upstream oil and gas exploration and production company. The company is a subsidiary of China National Offshore Oil Corporation. It engages in exploration, development, production and sale of crude oil and natural gas. It operates in four major oil production area …
  • PennWell Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' PennWell Corporation Mergers an …
  • PAR Technology Corporation (PAR):企業財務及び戦略的SWOT分析
    Summary PAR Technology Corporation (PAR) is a technology company that provides systems and service solutions with focus on developing and offering advanced Cloud and IoT technologies to various industries. Its service portfolio includes on-site field services, deployment services, depot repair, proj …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆